These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9780850

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
    Gulyás B, Halldin C, Karlsson P, Chou YH, Swahn CG, Bönöczk P, Farde L.
    Orv Hetil; 1999 Jul 25; 140(30):1687-91. PubMed ID: 10461449
    [Abstract] [Full Text] [Related]

  • 6. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A.
    Ideggyogy Sz; 2007 Jul 30; 60(7-8):301-10. PubMed ID: 17713111
    [Abstract] [Full Text] [Related]

  • 7. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
    Gulyás B, Halldin C, Sandell J, Karlsson P, Sóvágó J, Kárpáti E, Kiss B, Vas A, Cselényi Z, Farde L.
    Acta Neurol Scand; 2002 Dec 30; 106(6):325-32. PubMed ID: 12460136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
    Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B.
    Orv Hetil; 2002 Nov 24; 143(47):2631-6. PubMed ID: 12532649
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D.
    Ideggyogy Sz; 2003 May 20; 56(5-6):166-72. PubMed ID: 12861957
    [Abstract] [Full Text] [Related]

  • 15. Determination of regional cerebral blood flow in patients with cerebral infarction. Use of fluoromethane labeled with fluorine 18 and positron emission tomography.
    Celesia GG, Polcyn RE, Holden JE, Nickles RJ, Koeppe RA, Gatley SJ.
    Arch Neurol; 1984 Mar 20; 41(3):262-7. PubMed ID: 6607723
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T, Tanabe M, Shimamoto N, Kawazoe K, Hirata M.
    Arzneimittelforschung; 1984 Mar 20; 34(2):161-9. PubMed ID: 6539108
    [Abstract] [Full Text] [Related]

  • 18. [The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension].
    Spirin NN, Pizova NV, Shadrichev VA, Filatov VF, Bakucheva MV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007 Mar 20; 107(4):64-6. PubMed ID: 18688926
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N, Matsumoto S.
    Nihon Rinsho; 1985 Feb 20; 43(2):376-8. PubMed ID: 2987571
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.